Secondary outcome measures
| Nitric oxide | Dexamethasone | ||||||
|---|---|---|---|---|---|---|---|
| Treatment | Controls | Treatment | Controls | ||||
| Duration of ventilation (days)2-150 | 11 (5-44) | 19 (5-39) | 23 (6-44) | 13 (5-39) | |||
| Time to extubation (days)2-150 | 6.5 (5-28) | 11 (5-35) | 8.5 (5-35) | 11 (5-28) | |||
| Duration of hospitalisation (days)2-150 | 97 (74-112) | 96 (63-142) | 100 (63-142) | 95 (69-125) | |||
| Maximum grade of IVH2-150 | 2 (0-2) | 2 (0-3) | 2 (0-3) | 1 (0-3) | |||
| Pulmonary haemorrhage | 2 (10%) | 2 (10%) | 2 (10%) | 2 (10%) | |||
| Pneumothorax | 3 (15%) | 1 (5%) | 3 (14%) | 1 (5%) | |||
| Symptomatic PDA | 4 (20%) | 3 (15%) | 3 (14%) | 4 (19%) | |||
| Indomethacin | 3 (15%) | 1 (5%) | 1 (5%) | 2 (10%) | |||
| Ligation | 1 (5%) | 2 (10%) | 2 (10%) | 2 (10%) | |||
| Necrotising enterocolitis | 1 (5%) | 2 (10%) | 2 (10%) | 1 (5%) | |||
| Stage 3/4 ROP | 2 (10%) | 0 | 2 (10%) | 0 | |||
| Episodes of neonatal sepsis2-150 | 1 (0-3) | 1 (0-4) | 1 (0-3) | 1 (0-4) | |||
↵2-150 Values expressed as median (range).
ROP = retinopathy of prematurity.